Understanding how tau protein and small RNAs contribute to early Alzheimer's disease
The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesis
This study is looking at how a protein called tau and tiny RNA molecules work together in the brains of people with Alzheimer's disease, hoping to find clues that could help spot the disease earlier.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11086797 on NIH RePORTER |
What this research studies
This research investigates the relationship between tau protein and small non-coding RNAs (ncRNAs) in the context of Alzheimer's disease (AD). It aims to uncover how these molecules interact and influence the progression of AD by examining brain samples from patients. The study will analyze the expression levels of specific small RNAs in relation to tau protein aggregation and its effects on gene expression and chromatin accessibility. By understanding these mechanisms, the research seeks to identify potential early indicators of AD pathology.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease, particularly those showing early signs of cognitive decline.
Not a fit: Patients with advanced Alzheimer's disease or those without any cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new biomarkers for early detection of Alzheimer's disease and novel therapeutic targets.
How similar studies have performed: Previous research has shown promising results in understanding the role of tau and small RNAs in neurodegenerative diseases, indicating that this approach may yield valuable insights.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Koldamova, Radosveta — University of Pittsburgh at Pittsburgh
- Study coordinator: Koldamova, Radosveta
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.